CANAAN PARTNERS X LLC
Q3 2020 Form 13-F
MENLO PARK, CALIFORNIA
CIK 0001673228
· Institutional investment manager
$50.3M Reported Value Total
Reported value
$50.3M
Quarter over quarter
-36.3%
Holdings
3
Top-10 concentration
100.0%
Key People
Named on the latest Form 13-F filing — not necessarily an owner
Nancy Levenson
Attorney-in-Fact
Filing Navigation
13F Metrics
Loading 13F Metrics
Q3 2020 13F record
Q3 2020 13F filing summary
| Period of report | September 30, 2020 |
|---|---|
| Filed | October 26, 2020 |
| Form | 13F-HR |
| Reported value | $50.3M |
| Positions | 3 |
| Change in reported value | -39.7% |
| New positions | 0 |
| Exited positions | 0 |
| Position turnover | 0.0% |
| Top-10 concentration | 100.0% |
13F filings by quarter
| Quarter | Positions | Value |
|---|---|---|
|
Q3 2023 13F
Filed Oct 11, 2023
|
2 | $74.7M |
|
Q2 2023 13F
Filed Jul 13, 2023
|
3 | $84.1M |
|
Q1 2023 13F
Filed Apr 6, 2023
|
2 | $56.1M |
|
Q4 2022 13F
Filed Feb 1, 2023
|
2 | $56.9M |
|
Q3 2022 13F
Filed Oct 31, 2022
|
2 | $63.8M |
|
Q2 2022 13F
Filed Aug 10, 2022
|
3 | $57.8M |
|
Q1 2022 13F
Filed Apr 28, 2022
|
4 | $98.5M |
|
Q4 2021 13F
Filed Feb 3, 2022
|
4 | $256.5M |
|
Q3 2021 13F
Filed Nov 15, 2021
|
5 | $351.3M |
|
Q2 2021 13F
Filed Jul 22, 2021
|
3 | $66.6M |
|
Q1 2021 13F
Filed May 3, 2021
|
3 | $73.4M |
|
Q4 2020 13F
Filed Feb 2, 2021
|
3 | $48.1M |
|
Q3 2020 13F
Filed Oct 26, 2020
|
3 | $50.3M |
|
Q2 2020 13F
Filed Aug 10, 2020
|
3 | $83.4M |
|
Q1 2020 13F
Filed May 11, 2020
|
3 | $90.9M |
|
Q4 2019 13F
Filed Jan 27, 2020
|
3 | $154.7M |
Top 3 holdings · Q3 2020
| # | Holding | Reported value | % of portfolio |
|---|---|---|---|
| 1 | IDYA IDEAYA Biosciences Inc | $33.4M | 66.44% |
| 2 | NXTC NextCure Inc | $15.1M | 29.94% |
| 3 | ITRM Iterum Therapeutics plc | $1.8M | 3.62% |
Values as reported on the Q3 2020 Form 13F. Every position is in the holdings table below.